Latest Insider Transactions at Xenon Pharmaceuticals Inc. (XENE)
This section provides a real-time view of insider transactions for Xenon Pharmaceuticals Inc. (XENE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Xenon Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Xenon Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2020
|
Michael M Tarnow Director |
SELL
Bona fide gift
|
Direct |
10,288
-12.86%
|
-
|
|
Oct 28
2020
|
Michael M Tarnow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,288
+6.24%
|
$30,864
$3.76 P/Share
|
|
Mar 27
2018
|
Bvf Partners L P > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,437,000
-79.94%
|
-
|